Selling and Marketing Expense in USD of AGILE THERAPEUTICS INC from 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Agile Therapeutics Inc quarterly/annual Selling and Marketing Expense history and change rate from 2018 to Q2 2024.
  • Agile Therapeutics Inc Selling and Marketing Expense for the quarter ending 30 Jun 2024 was $3.78M, a 17.4% decline year-over-year.
  • Agile Therapeutics Inc Selling and Marketing Expense for the twelve months ending 30 Jun 2024 was $16M, a 26.1% decline year-over-year.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2023 was $17.8M, a 41.5% decline from 2022.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2022 was $30.4M, a 30.1% decline from 2021.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2021 was $43.4M, a 86.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16M $3.78M -$794K -17.4% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $16.8M $3.68M -$988K -21.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $17.8M $3.73M -$3.12M -45.5% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $20.9M $4.8M -$760K -13.7% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $21.6M $4.57M -$2.84M -38.3% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $24.5M $4.67M -$5.88M -55.7% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $30.4M $6.85M -$5.98M -46.6% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $36.4M $5.56M -$3.83M -40.8% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $40.2M $7.41M -$4.57M -38.1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $44.7M $10.6M +$1.3M +14% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $43.4M $12.8M +$2.16M +20.2% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 $41.3M $9.39M +$1.66M +21.5% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $39.6M $12M +$8.83M +280% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $30.8M $9.25M +$7.51M +431% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $23.3M $10.7M 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2023
Q3 2020 $7.72M 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q2 2020 $3.15M 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021
Q1 2020 $1.74M 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021

AGILE THERAPEUTICS INC Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.8M -$12.6M -41.5% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $30.4M -$13.1M -30.1% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $43.4M +$20.2M +86.6% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 $23.3M +$22.2M +2046% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
2019 $1.09M +$143K +15.2% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 $942K 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.